Cargando…
Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma
BACKGROUND: Zinc finger and bric-a-brac/tramtrack/broad (ZBTB) domain-containing proteins have been reported to be associated with many tumors’ development. However, in tumor initiation and progression, the role of ZBTB9, one of the protein family, and its prognostic value were yet to be elucidated...
Autores principales: | Zhang, Zhenshan, Wu, Leilei, Li, Juan, Chen, Jiayan, Yu, Qi, Yao, Hui, Xu, Yaping, Liu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756481/ https://www.ncbi.nlm.nih.gov/pubmed/36522647 http://dx.doi.org/10.1186/s12967-022-03790-0 |
Ejemplares similares
-
Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer
por: Yang, Zhe, et al.
Publicado: (2023) -
ZBTB20 regulates EGFR expression and hepatocyte proliferation in mouse liver regeneration
por: Zhang, Hai, et al.
Publicado: (2018) -
BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27
por: He, Jin, et al.
Publicado: (2020) -
Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches
por: Yue, Li, et al.
Publicado: (2021) -
HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma
por: He, Zebao, et al.
Publicado: (2020)